Lenk, Lennart
Carlet, Michela
Vogiatzi, Fotini
Spory, Lea
Winterberg, Dorothee
Cousins, Antony http://orcid.org/0000-0003-1516-2515
Vossen-Gajcy, Michaela
Ibruli, Olta
Vokuhl, Christian
Cario, Gunnar
El Ayoubi, Omar
Kramer, Lisa
Ritgen, Matthias
Brüggemann, Monika
Häsler, Robert
Schrappe, Martin
Fuhrmann, Stephan http://orcid.org/0000-0002-7785-2565
Halsey, Christina http://orcid.org/0000-0001-5449-5246
Jeremias, Irmela http://orcid.org/0000-0003-1773-7677
Hobeika, Elias
Jumaa, Hassan http://orcid.org/0000-0003-3383-141X
Alsadeq, Ameera http://orcid.org/0000-0003-0568-9890
Schewe, Denis M. http://orcid.org/0000-0002-1070-0217
Article History
Received: 30 June 2020
Accepted: 25 November 2020
First Online: 15 January 2021
Competing interests
: The authors declare the following competing interests: M.B. received consulting fees from PRMA, research funding from Amgen, honoraria from Novartis, Pfizer, and Amgen and was an advisory board member for Incyte and Amgen. D.M.S. was an advisory board member for Bayer, SOBI and Jazz Pharmaceuticals and received research funding from OSE Pharmaceuticals. M.S. received research funding from Shire, and from Servier, as well as fees for Advisory Board functions from Jazzpharma, and Servier. The other authors declare no competing interests.